These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 21288305)

  • 41. The active core in a triazole peptide dual-site antagonist of HIV-1 gp120.
    Umashankara M; McFadden K; Zentner I; Schön A; Rajagopal S; Tuzer F; Kuriakose SA; Contarino M; Lalonde J; Freire E; Chaiken I
    ChemMedChem; 2010 Nov; 5(11):1871-9. PubMed ID: 20677318
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Potent inhibition of HIV-1 fusion by cyanovirin-N requires only a single high affinity carbohydrate binding site: characterization of low affinity carbohydrate binding site knockout mutants.
    Chang LC; Bewley CA
    J Mol Biol; 2002 Apr; 318(1):1-8. PubMed ID: 12054763
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Partially Open HIV-1 Envelope Structures Exhibit Conformational Changes Relevant for Coreceptor Binding and Fusion.
    Wang H; Barnes CO; Yang Z; Nussenzweig MC; Bjorkman PJ
    Cell Host Microbe; 2018 Oct; 24(4):579-592.e4. PubMed ID: 30308160
    [TBL] [Abstract][Full Text] [Related]  

  • 44. CD4-binding obstacles in conformational transitions and allosteric communications of HIV gp120.
    Li Y; Guo YC; Zhang XL; Deng L; Sang P; Yang LQ; Liu SQ
    Biochim Biophys Acta Biomembr; 2020 Jun; 1862(6):183217. PubMed ID: 32061646
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Intrinsic Thermodynamics of Protein-Ligand Binding by Isothermal Titration Calorimetry as Aid to Drug Design.
    Paketurytė V; Zubrienė A; Ladbury JE; Matulis D
    Methods Mol Biol; 2019; 1964():61-74. PubMed ID: 30929235
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The glycan-mediated mechanism on the interactions of gp120 with CD4 and antibody: Insights from molecular dynamics simulation.
    Zhang Y; Niu Y; Tian J; Liu X; Yao X; Liu H
    Chem Biol Drug Des; 2017 Dec; 90(6):1237-1246. PubMed ID: 28632942
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody.
    Kwong PD; Wyatt R; Robinson J; Sweet RW; Sodroski J; Hendrickson WA
    Nature; 1998 Jun; 393(6686):648-59. PubMed ID: 9641677
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Compensating enthalpic and entropic changes hinder binding affinity optimization.
    Lafont V; Armstrong AA; Ohtaka H; Kiso Y; Mario Amzel L; Freire E
    Chem Biol Drug Des; 2007 Jun; 69(6):413-22. PubMed ID: 17581235
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Conformational changes induced in the human immunodeficiency virus envelope glycoprotein by soluble CD4 binding.
    Sattentau QJ; Moore JP
    J Exp Med; 1991 Aug; 174(2):407-15. PubMed ID: 1713252
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Interactions of HIV-1 proteins gp120 and Nef with cellular partners define a novel allosteric paradigm.
    Leavitt SA; SchOn A; Klein JC; Manjappara U; Chaiken IM; Freire E
    Curr Protein Pept Sci; 2004 Feb; 5(1):1-8. PubMed ID: 14965316
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Expression and characterization of a single-chain polypeptide analogue of the human immunodeficiency virus type 1 gp120-CD4 receptor complex.
    Fouts TR; Tuskan R; Godfrey K; Reitz M; Hone D; Lewis GK; DeVico AL
    J Virol; 2000 Dec; 74(24):11427-36. PubMed ID: 11090138
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A minimally cytotoxic CD4 mimic as an HIV entry inhibitor.
    Mizuguchi T; Harada S; Miura T; Ohashi N; Narumi T; Mori H; Irahara Y; Yamada Y; Nomura W; Matsushita S; Yoshimura K; Tamamura H
    Bioorg Med Chem Lett; 2016 Jan; 26(2):397-400. PubMed ID: 26706175
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Identification of CD4 and major histocompatibility complex functional peptide sites and their homology with oligopeptides from human immunodeficiency virus type 1 glycoprotein gp120: role in AIDS pathogenesis.
    Zagury JF; Bernard J; Achour A; Astgen A; Lachgar A; Fall L; Carelli C; Issing W; Mbika JP; Picard O
    Proc Natl Acad Sci U S A; 1993 Aug; 90(16):7573-7. PubMed ID: 8356059
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Biochemical and genetic characterizations of a novel human immunodeficiency virus type 1 inhibitor that blocks gp120-CD4 interactions.
    Guo Q; Ho HT; Dicker I; Fan L; Zhou N; Friborg J; Wang T; McAuliffe BV; Wang HG; Rose RE; Fang H; Scarnati HT; Langley DR; Meanwell NA; Abraham R; Colonno RJ; Lin PF
    J Virol; 2003 Oct; 77(19):10528-36. PubMed ID: 12970437
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Neutralizing antibodies against the V3 loop of human immunodeficiency virus type 1 gp120 block the CD4-dependent and -independent binding of virus to cells.
    Valenzuela A; Blanco J; Krust B; Franco R; Hovanessian AG
    J Virol; 1997 Nov; 71(11):8289-98. PubMed ID: 9343181
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Kinetic and thermodynamic characterization of HIV-1 protease inhibitors.
    Shuman CF; Hämäläinen MD; Danielson UH
    J Mol Recognit; 2004; 17(2):106-19. PubMed ID: 15027031
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Characterization of the conformational state and flexibility of HIV-1 glycoprotein gp120 core domain.
    Pan Y; Ma B; Keskin O; Nussinov R
    J Biol Chem; 2004 Jul; 279(29):30523-30. PubMed ID: 15131118
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Resistance of primary isolates of human immunodeficiency virus type 1 to neutralization by soluble CD4 is not due to lower affinity with the viral envelope glycoprotein gp120.
    Turner S; Tizard R; DeMarinis J; Pepinsky RB; Zullo J; Schooley R; Fisher R
    Proc Natl Acad Sci U S A; 1992 Feb; 89(4):1335-9. PubMed ID: 1741386
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of the I559P gp41 change on the conformation and function of the human immunodeficiency virus (HIV-1) membrane envelope glycoprotein trimer.
    Alsahafi N; Debbeche O; Sodroski J; Finzi A
    PLoS One; 2015; 10(4):e0122111. PubMed ID: 25849367
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Protein-disulfide isomerase-mediated reduction of two disulfide bonds of HIV envelope glycoprotein 120 occurs post-CXCR4 binding and is required for fusion.
    Barbouche R; Miquelis R; Jones IM; Fenouillet E
    J Biol Chem; 2003 Jan; 278(5):3131-6. PubMed ID: 12218052
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.